Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1988 | 06-1988 | 03-1988 | 12-1987 | 09-1987 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,512 | 10,804 | 11,967 | 11,962 | 12,356 |
| Receivables | 773 | 286 | 349 | 255 | 269 |
| Inventories | 127 | 80 | 79 | 69 | 60 |
| Other current assets | 87 | 457 | 106 | 312 | 362 |
| TOTAL | $11,498 | $11,626 | $12,501 | $12,598 | $13,047 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 460 | 469 | 64 | 48 | 49 |
| TOTAL | $460 | $469 | $64 | $48 | $49 |
| Total Assets | $12,822 | $12,969 | $13,346 | $13,401 | $13,868 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 108 | 147 | 100 | 65 | 119 |
| Accrued Expenses | 907 | 594 | 612 | 497 | 495 |
| Other current liabilities | 376 | 0 | 579 | 520 | 693 |
| TOTAL | $1,392 | $741 | $1,291 | $1,082 | $1,306 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 486 | 0 | 0 | 0 |
| TOTAL | $N/A | $486 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,392 | $1,227 | $1,291 | $1,082 | $1,306 |
| Shareholders' Equity | |||||
| Common Shares | 8 | 8 | 8 | 8 | 8 |
| Retained earnings | -5,228 | -4,915 | -4,601 | -4,337 | -4,094 |
| Other shareholders' equity | 2,327 | 2,467 | 2,466 | 2,466 | 2,467 |
| TOTAL | $11,430 | $11,742 | $12,056 | $12,319 | $12,562 |
| Total Liabilities And Equity | $12,822 | $12,969 | $13,347 | $13,401 | $13,868 |